RMC ACTIONS. In taking actions by the RMC, each Party shall have one vote. If the RMC fails to reach unanimity on a matter before it for decision, the matter shall be referred for resolution to the CEO of Rigel and the V.P. of Biological Research of ▇▇▇▇▇▇▇ for their consideration and agreement. If they are unable to agree after negotiation in good faith, the matter shall be resolved consistent with ▇▇▇▇▇▇▇'▇ position; PROVIDED, HOWEVER, that solely in connection with technical issues involving Rigel Technology such as, for example, how to carry out a certain experiment or which technique to be applied to obtain a certain result, such issues shall be resolved consistent with Rigel's position. Strategic decisions such as, for example, selection of Preliminary Target Peptide Pairs for further validation and the criteria for such validation, shall be resolved consistent with ▇▇▇▇▇▇▇'▇ position. [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Appears in 2 contracts
Sources: Collaboration Agreement (Rigel Pharmaceuticals Inc), Collaboration Agreement (Rigel Pharmaceuticals Inc)